PCSA
PROCESSA (PCSA)
NASDAQ
$2.02$0.00 (0.00%)
Price as of Jun 23, 2026 5:13 PM EDT
  • $5.7M
    Market Cap
  • -69.75%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-7.8M
+7.45%
-7.3M
+25.34%
-5.8M
-49.54%
-11.5M
+54.40%
Depreciation and Amortization Expense
1,204
+53.96%
782
+252.25%
222
-99.97%
788,495
-0.25%
Total Operating Expenses
6.2M
+29.19%
4.8M
-15.47%
5.7M
-35.44%
8.8M
+86.89%
Operating Profit
-14.0M
+16.08%
-12.1M
+5.19%
-11.5M
-58.38%
-27.5M
+126.85%
Interest Income
109,491
-45.55%
201,088
-40.07%
335,541
+231.56%
101,202
+744.12%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
109,491
-45.55%
201,088
-40.07%
335,541
+231.56%
101,202
+770.41%
Total Nonoperating Income and Expense
20,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-13.6M
+14.46%
-11.9M
+6.55%
-11.1M
-59.45%
-27.4M
+129.34%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-13.6M
+14.46%
-11.9M
+6.55%
-11.1M
-59.45%
-27.4M
+139.98%
Net Income from Continuing Operations Applicable to Common
-13.6M
+14.46%
-11.9M
+6.55%
-11.1M
-59.45%
-27.4M
+129.34%
Basic EPS and Net Income
-10.36
+167.70%
-3.87
-54.36%
-8.48
+398.82%
-1.70
+126.67%
Diluted EPS and Net Income
-10.36
+167.70%
-3.87
-54.36%
-8.48
+398.82%
-1.70
+126.67%
Basic Weighted Average Shares
1.3M
-57.21%
3.1M
+133.30%
1.3M
-91.86%
16.1M
+5.16%
Diluted Weighted Average Shares
1.3M
-57.21%
3.1M
+133.30%
1.3M
-91.86%
16.1M
+5.16%
Balance Sheet
Cash and Cash Equivalents
5.5M
+364.77%
1.2M
-74.69%
4.7M
-27.64%
6.5M
-60.58%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.5M
+364.77%
1.2M
-74.69%
4.7M
-27.64%
6.5M
-60.58%
Total Current Assets
5.7M
+202.67%
1.9M
-66.74%
5.6M
-32.84%
8.4M
-54.24%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3,812
-24.00%
5,016
+96.40%
2,554
N/A
N/A
N/A
Total Long-Term Assets
3,812
-99.70%
1.3M
+22,925.15%
5,535
-97.63%
233,122
-97.13%
Total Assets
7.8M
+141.96%
3.2M
-44.19%
5.8M
-32.87%
8.6M
-67.43%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
51
-97.12%
Total Current Liabilities
2.2M
+45.91%
1.5M
+109.78%
730,579
-26.84%
998,556
+2.84%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
66,905
0.00%
66,905
-55.56%
150,554
+1,938.65%
Total Liabilities
2.2M
+45.86%
1.5M
+92.24%
797,484
-30.60%
1.1M
+17.45%
Retained Earnings
-100.8M
+15.55%
-87.2M
+15.72%
-75.4M
+17.31%
-64.2M
+74.48%
Total Stockholders Equity
5.6M
+228.82%
1.7M
-66.00%
5.0M
-33.22%
7.5M
-70.69%
Total Shares Outstanding
2.6M
-30.54%
3.7M
+187.92%
1.3M
-91.98%
16.0M
+2.07%
Cash Flow
Cash from Operating Activities
-11.4M
+1.25%
-11.2M
+39.46%
-8.1M
-16.05%
-9.6M
+10.18%
Capital Expenditures
N/A
N/A
3,244
+16.86%
2,776
N/A
N/A
N/A
Cash from Investing Activities
-850,000
+26,102.22%
-3,244
+16.86%
-2,776
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
16.6M
+114.40%
7.7M
+23.37%
6.3M
+1,712.15%
-388,843
-103.97%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-245.66%
-6.55%
-262.87%
+70.26%
-154.40%
-1.24%
-156.34%
+253.50%
Return on Equity
-372.97%
+5.21%
-354.51%
+98.59%
-178.52%
+7.26%
-166.43%
+252.63%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.54
+107.44%
1.22
-84.14%
7.71
-8.21%
8.40
-55.50%
Cash Ratio
2.48
+218.54%
0.78
-87.93%
6.44
-1.09%
6.51
-61.67%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow